Following our exciting collaborations with both Merck KGaA, Darmstadt, Germany, and Novartis, and with an expanding small molecule drug discovery portfolio, Artios Pharma is recruiting for a Financial Accountant. This is an excellent opportunity to join a world class research team in a dynamic, small Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic.

Regulatory Affairs Manager – Centre for Drug Development

Location: Stratford or home based.

Salary: £41,000 - £50,000 may have flexibility depending on experience.

Contract: Permanent, 35 hours per week. Open to compressed hours or part time working requests (equivalent to 4 days a week).

Closing date: Sunday 14th of November 11:59. Do not delay applying as we are shortlisting on application and may close earlier should a suitable candidate be found.

Due to an acceleration in exciting, scientific growth at the Institute, DNA Pipelines Technology Development is expanding its team of automation specialists. We are looking for experienced automation specialists to develop and adapt novel or existing automated liquid handling workflows to promote the ability of DNA Pipelines to support faculty science at scale.

As our automation specialist you will have the opportunity to join a team which takes a collaborative approach to project delivery and works in partnership with other Sci-Ops groups to deliver strategic goals.

About the Role

This role leads the development and delivery of the School of Medicine and Dentistry’s (SMD) Commercialisation portfolio in Biopharma, as the key point of contact for commercial innovation matters. The Assistant Director Commercialisation supervises a technology transfer team with two direct reports, within a larger team of eight. The role provides strategic direction, advice and training on all aspects of intellectual property and technology commercialization to University management, researchers and students.

About You

Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.

ELIXIR is seeking an enthusiastic and collaborative self-starter to join us as an Industry Officer.

Research Immunologist - Target Identification 

Based in Oxfordshire

Competitive Salary + Excellent Benefits

Are you an Immunologist with experience in new target discovery and validation?

Would you like to work for a well-funded Biotech developing the next generation of oncology therapeutics?

Company Description

We are a leader in liquid biopsy. Every day we transform the lives of cancer patients and their families through the power of liquid biopsy. Our tests unlock essential genomic information from a simple blood test and allow clinicians to make more informed treatment decisions for their patients.

Principal Medicinal Chemist

Oxfordshire based, with significant remote/home working

Competitive Salary, Commensurate with Experience

Do you have significant experience leading Medicinal Chemistry activities?

Would you like to work for a well-funded Immuno-Oncology Biotech in Oxfordshire?

My client are a well-funded Biotechnology company working within oncology therapeutics, using novel Immuno-Oncology and Immuno-inflammation approaches to drug discovery and development.

OMass Therapeutics is an early stage drug discovery company specialized in applying state of the art biophysical platform technologies to discover therapies for severe unmet medical needs in immunology and genetically defined disorders. The company was founded by Professor Dame Carol Robinson to leverage her pioneering work in native mass spectrometry, in studies of dynamic protein assemblies, to characterise challenging drug targets including membrane proteins. The high resolution of our biophysical platform offers an unprecedented advantage in the detection of drug leads.